Weiss et al. has previously demonstrated that MYCN has the potential to drive murine neuroblastoma in a transgenic model, in which MYCN expression is driven by a rat tyrosine hydroxylase (TH) promoter.6 Transgenic mice expressing MYCN in the abdominal ganglia developed neuroblastoma. The gene discussed is MYCN; the disease is neuroblastoma.